These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 19472977)

  • 1. Competitive inhibition of human poly(A)-specific ribonuclease (PARN) by synthetic fluoro-pyranosyl nucleosides.
    Balatsos NA; Vlachakis D; Maragozidis P; Manta S; Anastasakis D; Kyritsis A; Vlassi M; Komiotis D; Stathopoulos C
    Biochemistry; 2009 Jul; 48(26):6044-51. PubMed ID: 19472977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic and in silico analysis of the slow-binding inhibition of human poly(A)-specific ribonuclease (PARN) by novel nucleoside analogues.
    Balatsos N; Vlachakis D; Chatzigeorgiou V; Manta S; Komiotis D; Vlassi M; Stathopoulos C
    Biochimie; 2012 Jan; 94(1):214-21. PubMed ID: 22041582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of magnesium ions on the thermal stability of human poly(A)-specific ribonuclease.
    Liu WF; Zhang A; Cheng Y; Zhou HM; Yan YB
    FEBS Lett; 2007 Mar; 581(5):1047-52. PubMed ID: 17306797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly(A)-specific ribonuclease (PARN): an allosterically regulated, processive and mRNA cap-interacting deadenylase.
    Virtanen A; Henriksson N; Nilsson P; Nissbeck M
    Crit Rev Biochem Mol Biol; 2013; 48(2):192-209. PubMed ID: 23496118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis of m(7)GpppG binding to poly(A)-specific ribonuclease.
    Wu M; Nilsson P; Henriksson N; Niedzwiecka A; Lim MK; Cheng Z; Kokkoris K; Virtanen A; Song H
    Structure; 2009 Feb; 17(2):276-86. PubMed ID: 19217398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of human poly(A)-specific ribonuclease (PARN) by purine nucleotides: kinetic analysis.
    Balatsos NA; Anastasakis D; Stathopoulos C
    J Enzyme Inhib Med Chem; 2009 Apr; 24(2):516-23. PubMed ID: 18763168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The R3H domain stabilizes poly(A)-specific ribonuclease by stabilizing the RRM domain.
    Liu WF; Zhang A; He GJ; Yan YB
    Biochem Biophys Res Commun; 2007 Sep; 360(4):846-51. PubMed ID: 17624302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative inhibitory activity of 3'- and 5'-functionalized nucleosides on ribonuclease A.
    Debnath J; Dasgupta S; Pathak T
    Bioorg Med Chem; 2010 Dec; 18(23):8257-63. PubMed ID: 21041096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure of the RRM domain of poly(A)-specific ribonuclease reveals a novel m(7)G-cap-binding mode.
    Monecke T; Schell S; Dickmanns A; Ficner R
    J Mol Biol; 2008 Oct; 382(4):827-34. PubMed ID: 18694759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allosteric regulation of human poly(A)-specific ribonuclease by cap and potassium ions.
    Liu WF; Zhang A; Cheng Y; Zhou HM; Yan YB
    Biochem Biophys Res Commun; 2009 Feb; 379(2):341-5. PubMed ID: 19103158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleoside-amino acid conjugates: An alternative route to the design of ribonuclease A inhibitors.
    Debnath J; Dasgupta S; Pathak T
    Bioorg Med Chem; 2009 Jul; 17(14):4921-7. PubMed ID: 19540766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and purification of recombinant poly(A)-specific ribonuclease (PARN).
    Nilsson P; Virtanen A
    Int J Biol Macromol; 2006 Aug; 39(1-3):95-9. PubMed ID: 16620953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular recognition of mRNA 5' cap by 3' poly(A)-specific ribonuclease (PARN) differs from interactions known for other cap-binding proteins.
    Niedzwiecka A; Nilsson P; Worch R; Stepinski J; Darzynkiewicz E; Virtanen A
    Biochim Biophys Acta; 2016 Apr; 1864(4):331-45. PubMed ID: 26772900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissimilar roles of the four conserved acidic residues in the thermal stability of poly(A)-specific ribonuclease.
    He GJ; Liu WF; Yan YB
    Int J Mol Sci; 2011; 12(5):2901-16. PubMed ID: 21686157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An integrated in silico approach to design specific inhibitors targeting human poly(a)-specific ribonuclease.
    Vlachakis D; Pavlopoulou A; Tsiliki G; Komiotis D; Stathopoulos C; Balatsos NA; Kossida S
    PLoS One; 2012; 7(12):e51113. PubMed ID: 23236441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the RRM domain in the activity, structure and stability of poly(A)-specific ribonuclease.
    Zhang A; Liu WF; Yan YB
    Arch Biochem Biophys; 2007 May; 461(2):255-62. PubMed ID: 17391638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of poly(A)-specific ribonuclease (PARN): current knowledge and perspectives.
    Balatsos NA; Maragozidis P; Anastasakis D; Stathopoulos C
    Curr Med Chem; 2012; 19(28):4838-49. PubMed ID: 22834816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of aspartic acid-203 in human thymidine phosphorylase as an important residue for both catalysis and non-competitive inhibition by the small molecule "crystallization chaperone" 5'-O-tritylinosine (KIN59).
    Bronckaers A; Aguado L; Negri A; Camarasa MJ; Balzarini J; Pérez-Pérez MJ; Gago F; Liekens S
    Biochem Pharmacol; 2009 Aug; 78(3):231-40. PubMed ID: 19389384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global architecture of human poly(A)-specific ribonuclease by atomic force microscopy in liquid and dynamic light scattering.
    Niedzwiecka A; Lekka M; Nilsson P; Virtanen A
    Biophys Chem; 2011 Oct; 158(2-3):141-9. PubMed ID: 21741754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cap-dependent deadenylation of mRNA.
    Dehlin E; Wormington M; Körner CG; Wahle E
    EMBO J; 2000 Mar; 19(5):1079-86. PubMed ID: 10698948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.